혈액암 (AML/ALL) | 바이오모아

ADCCBiologicAcademic and Community Cancer R…Phase 2

Cabozantinib (Cabozantinib)

Locally Advanced Hepatocellular Carcinoma; Metastatic Hepatocellular Carcinoma · FRα

#FR#ADC#Phase2#인기#항체약물접합체+5

효능 ORR 59%임상시험 89상태 DISCONTINUED

AntibodyARochePhase 3

atezolizumab (Tecentriq, MPDL3280A, Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody)

Carcinoma, Non-Squamous Non-Small Cell Lung · PD-L1

#PD-L1#Antibody#Phase3#인기#항체+5

효능 ORR 76.7%임상시험 88상태 ACTIVE

ADCABiologicJanssen Research & Development,…Phase 3

Osimertinib (Osimertinib)

Carcinoma, Non-Small-Cell Lung · FRα

#FR#ADC#Phase3#인기#항체약물접합체+4

효능 ORR 76.7%임상시험 88상태 RECRUITING

ADCBBiologicDaiichi SankyoPhase 2

Fixed dose (Patritumab Deruxtecan, Patritumab Deruxtecan (Fixed dose))

Non-Small Cell Lung Cancer Metastatic; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor · Non-Small Cell Lung Cancer Metastatic

#Non-SmallCellLungCancerMetastati#ADC#Phase2#인기#항체약물접합체+4

효능 ORR 64%임상시험 88상태 RECRUITING

ADCBBiologicDaiichi Sankyoderuxtecan, sacituzumab gov…Phase 2

Up-Titration (Patritumab Deruxtecan, Patritumab Deruxtecan (Up-Titration))

Non-Small Cell Lung Cancer Metastatic; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor · Non-Small Cell Lung Cancer Metastatic

#Non-SmallCellLungCancerMetastati#ADC#Phase2#인기#항체약물접합체+5

효능 ORR 64%임상시험 88상태 RECRUITING

ADCBBiologicGileadaxisPhase 3

sacituzumab govitecan (Trodelvy)

Breast Cancer; Metastatic Breast Cancer · Locally Advanced or Metastatic Urothelia

#LocallyAdvancedorMetastaticUroth#ADC#Phase3#인기#항체약물접합체+5

효능 ORR 44%임상시험 87상태 RECRUITING

AntibodyCEli Lilly and CompanyDeruxtecan]Phase 3

Ramucirumab (Ramucirumab)

Advanced Esophageal Adenocarcinoma; Advanced Gastric Adenocarcinoma · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase3#인기#항체+5

효능 ORR 40%임상시험 86상태 RECRUITING

ADCSBiologicDaiichi Sankyoderuxtecan (Dato-DXd, Datro…Phase 3

DS-8201a (Trastuzumab deruxtecan, Trastuzumab deruxtecan (DS-8201a))

Breast Cancer; Non-small Cell Lung Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+5

효능 ORR 79.7%임상시험 84상태 RECRUITING

AntibodyARocheGovitecanPhase 3

carboplatin-etoposide (Atezolizumab + chemotherapy, Atezolizumab + chemotherapy (carboplatin-etoposide))

Extensive Stage Small Cell Lung Cancer · Extensive Stage Small Cell Lung Cancer

#ExtensiveStageSmallCellLungCance#Antibody#Phase3#인기#항체+5

효능 ORR 100%임상시험 83상태 RECRUITING

AntibodyCAmgenPhase 3

Blinatumomab (Blinatumomab)

B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 · Precursor Cell Lymphoblastic Leukemia-Ly

#PrecursorCellLymphoblasticLeukem#Antibody#Phase3#인기#항체+5

효능 ORR 11.1%임상시험 83상태 RECRUITING

ADCCBiologicGroupe d'Etude Therapeutique de…Approved

Mercaptopurine (Mercaptopurine)

Crohn's Disease · Leukemia

#Leukemia#ADC#Approved#인기#항체약물접합체+4

효능 ORR 22%임상시험 79상태 RECRUITING

ADCCBiologicNovartis PharmaceuticalsdeliveryPhase 3

Trametinib (Trametinib)

KRAS G12C Mutant Solid Tumors; Carcinoma, Non-Small Cell Lung · FRα

#FR#ADC#Phase3#인기#항체약물접합체+5

효능 ORR 100%임상시험 79상태 DISCONTINUED

CGTBBiologicBioceltech Therapeutics, Ltd.Phase 1

CD19 CAR T cells (CD19 CAR T cells)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#인기#세포유전치료+5

효능 ORR 88%임상시험 73상태 RECRUITING

ADCBBiologicActinium PharmaceuticalsreleasePhase 2

Daunorubicin (Daunorubicin)

Acute Leukemia of Ambiguous Lineage; B Acute Lymphoblastic Leukemia · Leukemia

#Leukemia#ADC#Phase2#인기#항체약물접합체+5

효능 ORR 95%임상시험 72상태 RECRUITING

AntibodyCMiltenyi Biomedicine GmbHPhase 3

Alemtuzumab (Alemtuzumab)

Leukemia; Lymphoma · Fanconi Anemia

#FanconiAnemia#Antibody#Phase3#인기#항체+5

효능 ORR 33%임상시험 71상태 DISCONTINUED

ADCBBiologicTheRas, Inc., dPhase 2

mFOLFOX6 (mFOLFOX6)

Non-Small Cell Lung Cancer; NSCLC · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5

효능 ORR 63.64%임상시험 71상태 RECRUITING

ADCBiologicAlliance for Clinical Trials in…releasePhase 3

Daunorubicin Hydrochloride (Daunorubicin Hydrochloride)

B Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase3#인기#항체약물접합체+4

효능 ORR 95%임상시험 69상태 RECRUITING

ADCBiologicMerck Sharp & Dohme LLCPhase 3

Rescue Medication (Rescue Medication)

Non Small Cell Lung Cancer · Triple Negative Breast Neoplasms

#TripleNegativeBreastNeoplasms#ADC#Phase3#인기#항체약물접합체+3

임상시험 69상태 RECRUITING

ADCBiologicNeurocrine UK LimitedhasPhase 2

Therapeutic Hydrocortisone (Therapeutic Hydrocortisone)

Adult Burkitt Lymphoma; B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lympho… · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#인기#항체약물접합체+5

효능 ORR 6%임상시험 69상태 RECRUITING

ADCBiologicAGO Research GmbHPhase 3

Pegylated Liposomal Doxorubicin Hydrochloride (Pegylated Liposomal Doxorubicin Hydrochloride)

Plasma Cell Leukemia · Recurrent Platinum-Sensitive Fallopian T

#RecurrentPlatinum-SensitiveFallo#ADC#Phase3#인기#항체약물접합체+3

효능 ORR 64%임상시험 68상태 DISCONTINUED

2 / 43 페이지

← 이전 다음 →